Early Screening
Early risk screening for Alzheimer's disease
Early screening:Screening of people at high risk of AD
Non-invasive:Non-invasive sampling urine test
Hypersensitivity:Detection sensitivity up to picogram level
Accurate:The positive judgment value was 0.5ng/mL, and the detection rate was 95%
Fast:Results can be reported 10 minutes after the sample is dropped
Convenient:Add 100uL urine can be detected, easy to operate
Auxiliary Diagnosis
chemiluminescence detection reagent
Quantitative detection of trace amounts of beta-amyloid in urine using highly specific antibodies
Somatic gene detection model
Accurate prediction of future Alzheimer's disease in middle-aged individuals using molecular diagnostics and big data models
Interventional Therapy
traditional chinese medicine capsule
From the screening of thousands of traditional Chinese medicines, traditional Chinese medicines with excellent early intervention effect on AD have been found, which can effectively block the development of AD. At present, super-professional equipment has been purchased and is being tested, and the production line is also under construction. It is expected to be listed in 2025.
therapeutic drug
By increasing the natural phagocytic capacity of scavenger receptors on human monocytes, including P2X7, a new therapy is expected to completely cure Alzheimer's disease.
Domestic business consulting:86-0731-85714218
Company E-mail:yingxiao@qankorey.com
International Business Consulting:86-18874232226
Company E-mail:lisa@qankorey.com
Company address: 12F, Building 15, 188 Middle Huanbao Road, Yuhua District, Changsha, Hunan , 410116, China
Production Address: 4th Floor, Building 7, Yuhua Intelligent Manufacturing Center, No.2 Hongda Road, Tongsheng Street, Yuhua District, Changsha, Hunan , 410000, China
Public Number
Small program
Jingdong
Taobao